Successful treatment of encapsulating peritoneal sclerosis by hemodialysis and peritoneal lavage using dialysate containing dissolved hydrogen.

H2HUBB PLAIN-LANGUAGE TAKEAWAY The study adds to the molecular-hydrogen evidence base, but the available record does not support a firm conclusion about therapeutic benefit. Molecular hydrogen dialysis study 2015: what the findings mean This H2HUBB page translates the technical study record into consumer-friendly language while preserving the scientific details. The publication “Successful treatment of encapsulating […]

Read More

Translational Research of Peritoneal Dialysis Solution with Dissolved Molecular Hydrogen.

Histological study revealed a significant increase in the number of mesothelial cells and a significant decrease in peritoneal thickness in the H₂-PD group as compared to the control and PD groups. These findings come from a laboratory model and suggest molecular hydrogen's biological potential. Further research is needed to determine clinical relevance.

Read More

Effect of a hydrogen (H2)-enriched solution on the albumin redox of hemodialysis patients.

In 8 patients, however, the mean proportion of reversibly oxidized albumin in outlet serum was significantly lower than that in inlet serum following the H₂-HD session, whereas no significant changes were found in the standard solution session, suggesting that "intra-dialyzer" OS is reduced by H₂ -HD. This human hemodialysis study evaluated an H₂-enriched solution. Redox or peroxide terminology describes the biological context and does not change the identity of the molecular-hydrogen intervention.

Read More